Institute of Human Genetics, Polish Academy of Sciences

What Institute of Human Genetics, Polish Academy of Sciences does

The Institute of Human Genetics, Polish Academy of Sciences (Instytut Genetyki Człowieka PAN, IGC PAN) is a public, government-funded research institute headquartered at ul. Strzeszyńska 32, 60-479 Poznań, Poland, operating under the Polish Academy of Sciences (Polska Akademia Nauk). Its mission is to understand the genetic-molecular basis of disease etiopathogenesis and translate findings into clinical practice. The institute is organized into six research departments (Molecular and Translational Genetics, Nucleic Acid Function, Molecular Pathology, Advanced Biomedical Therapies and Infertility, Cancer Genetics, and Reproductive Biology and Genomics of Gamete), three independent research groups (RNA Biology, Non-coding Genome Functions, Regional Center for Digital Medicine), and three specialist laboratories including Bioinformatics and Spatial Multiomics.

Core technical capabilities span CRISPR-Cas9 gene editing, PAR-CLIP, chromatin immunoprecipitation, mass spectrometry-based proteomics, single-cell transcriptomics, and bioinformatics for large dataset analysis. Recent infrastructure additions include the Spatial Multiomics Laboratory (inaugurated May 2025) deploying 10x Genomics Visium HD spatial transcriptomics, and the Integrated Multi-Omics Platform for Metabolome and Microbiome Research Using Machine Learning (officially inaugurated May 2026). The institute also operates the Innowacyjne Centrum Medyczne (Innovative Medical Center), which provides certified clinical diagnostics including COVID-19 RT-PCR (270 PLN, 8-hour results), antigen testing (100 PLN, 1-hour results), differential COVID-19/influenza testing (300 PLN), Legionella pneumophila PCR (220 PLN, 5-day turnaround), and comprehensive bacterial identification via NGS (750 PLN, 10 business days).

The institute monetizes through three primary streams: (1) competitive research grants from Polish bodies (NCN, NCBiR) and European programs (Horizon 2020, FENG, European Social Fund), including the EUR 899,525 Horizon 2020 Twinning 'NEXT LEVEL' project coordinated with University of Ghent, University of Ulm, and University of Groningen; (2) clinical diagnostic services to individual patients via the Innovative Medical Center; and (3) postgraduate education through the International Doctoral School in English and the Poznań Doctoral School of Institutes of PAS. Customers span the academic research community (Polish and international universities), individual patients requiring certified molecular diagnostics, and domestic/international doctoral students. The institute holds the highest A+ category in the Polish Ministry of Science and Higher Education scientific evaluation for 2022-2025 and the European Commission's HR Excellence in Research Award.

Name

Institute of Human Genetics, Polish Academy of Sciences

Legal name

Instytut Genetyki Człowieka Polskiej Akademii Nauk

Website

https://igcz.poznan.pl

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

The Institute of Human Genetics, Polish Academy of Sciences (IGC PAN) is a public research institute in Poznań, Poland, conducting genetic-molecular disease research across six departments and offering clinical diagnostics, doctoral education, and multiomics research services.

Ownership category

akta.pro rank

Product category

Human Genetics Research

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• Human genetics research
• Molecular diagnostics
• Clinical genetic testing
• Biomedical research
• Doctoral education

Headquarters

HQ city

Poznań

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Research Grants: Funded by Polish and European research funding bodies including National Science Centre (NCN), National Centre for Research and Development (NCBiR), European Funds, and international collaborative programs
2. Clinical Diagnostic Services: COVID-19 testing (RT-PCR, antigen), Legionella pneumophila testing, bacterial identification via NGS sequencing, and other molecular diagnostics for individual patients
3. International Doctoral Programs: International Doctoral School in English and Poznań Doctoral School of Institutes of PAS, providing postgraduate education in molecular human genetics

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

The Institute of Human Genetics, Polish Academy of Sciences (Instytut Genetyki Człowieka PAN) is a public research institute that conducts fundamental genetic-molecular research on the ethiopathogenesis of human diseases and translates findings into clinical practice. It delivers certified molecular diagnostic services through its Innovative Medical Center (COVID-19 RT-PCR/antigen, Legionella, NGS-based bacterial identification, differential influenza testing) and runs an English-language International Doctoral School in human molecular genetics.

Product overview

The Institute of Human Genetics, Polish Academy of Sciences operates as a research institution providing both diagnostic services and academic research programs. Its primary service offering is the Innowacyjne Centrum Medyczne (Innovative Medical Center), which delivers molecular diagnostic testing including COVID-19 RT-PCR and antigen tests, differential COVID-19/influenza testing, Legionella pneumophila PCR testing, and bacterial identification via next-generation sequencing. The institute also houses specialized research laboratories including the Spatial Multiomics Laboratory and the Integrated Multi-Omics Platform for metabolome and microbiome research using machine learning. On the academic side, the institute operates an International Doctoral School offering English-language PhD programs in human molecular genetics with training in advanced methodologies. Research activities are organized across six departments covering molecular genetics, nucleic acid function, molecular pathology, advanced biomedical therapies, cancer genetics, and reproductive biology.

Differentiator

Problem solved

Functional benefit

Brands

• Innowacyjne Centrum Medyczne (Innovative Medical Center): Medical center providing COVID-19 testing, bacterial infection diagnostics, and clinical services
• Międzynarodowe Studia Doktoranckie (International Doctoral School)

Products and services

• COVID-19 RT-PCR Testing Service RT-PCR molecular diagnostic testing for SARS-CoV-2 virus detection, available 7 days a week with results within 8 hours. Tests are accredited by the Polish Ministry of Health and recognized by international airlines.

Quantifiable outcome

• A+ category achieved in scientific quality evaluation for 2022-2025
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Eight partnerships are on record, tiered core, minor and major.

• University of Ghent (Belgium)coreStrategic or Co-development Partner · 1 January 2021Horizon 2020 Twinning project 'NEXT LEVEL' partners for excellence in hematologic neoplasms research. Project funding of EUR 899,525 to enhance research excellence through collaboration with leading European institutions.
• University of Ulm (Germany)coreStrategic or Co-development Partner · 1 January 2021Horizon 2020 Twinning project partner for hematologic neoplasms research collaboration, contributing to research excellence enhancement alongside University of Ghent and University of Groningen.
• University of Groningen (Netherlands)coreStrategic or Co-development Partner · 1 January 2021Horizon 2020 Twinning project partner for excellence in hematologic neoplasms research, providing European research network integration.
• Ministry of Science and Technology of China (MOST)coreStrategic or Co-development Partner · 1 January 2019First Polish-Chinese Joint Research Call partner for 'Double impact of BCL11B gene suppression for targeted therapy of T-cell neoplasms' project, led by Prof. Grzegorz Przybylski.
• DNA Research Center Ltd.minorStrategic or Co-development Partner · 1 January 2018Consortium partner in Intelligent Development Operational Program project 'Liquid biopsy' for cancer fingerprint detection in head and neck cancer patients.
• Genomed Inc.minorStrategic or Co-development Partner · 1 January 2018Consortium partner in Smart Growth Operational Programme project for salivary gland adenoma proliferation assessment using NGS techniques.
• Poznan University of Medical SciencesmajorStrategic or Co-development Partner · 1 January 2018Lead consortium partner in multiple joint research projects including liquid biopsy for cancer detection, salivary gland adenoma NGS project, and STRATEGMED III acute lymphoblastic leukemia research (PersonALL project).
• Adam Mickiewicz University / Poznań Science and Technology ParkminorStrategic or Co-development Partner · 1 January 2017Regional Focal Point network for EU Framework Programmes, supporting participation in EU framework programs in Wielkopolska and Lubuskie provinces.

Scale indicators4 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• European Molecular Biology Laboratory (EMBL): Intergovernmental research organization in molecular life sciences with multiple sites across Europe. Comparable in genomics research, multi-omics platforms, and clinical/translational focus, but operating at significantly larger scale and geographic scope.
• Wellcome Sanger Institute: UK-based genomics and genetics research institute. Directly comparable in focus on human genetics, cancer genomics, and clinical translation, though at substantially larger scale with global influence in genomic medicine initiatives.
• Pasteur Institute: French research institute focused on infectious disease, microbiology, and molecular biology. Comparable in combining fundamental research with clinical diagnostic services (COVID-19 testing, bacterial identification), and in broad biomedical research mission.
• Broad Institute of MIT and Harvard: Major US genomics research institute with focus on genetic basis of disease, cancer genomics, and psychiatric disease. Comparable in genomics research depth and translational goals (clinical diagnostics, therapeutic targets), but operates at much larger scale with significant private funding.
• Max Planck Institute for Molecular Genetics: Major German research institute focused on molecular genetics, genomics, and biomedical research. Comparable in research focus (human genetics, molecular pathology, genome biology) and academic institutional structure, with broader resources and international network.

Regional players

• Helmholtz Centre for Infection Research: German research center focused on infection biology and immunology. Comparable in multi-omics approaches, infectious disease research, and Next-Generation Sequencing applications, but with broader regional mandate and larger funding base.

Direct peers

• Nencki Institute of Experimental Biology PAS: Polish Academy of Sciences institute focused on neurobiology, cell biology, and molecular biology. Direct peer in PAS institutional structure, scientific research focus, and Polish national research framework.
• International Institute of Molecular and Cell Biology in Warsaw (IIMCB): Polish research institute (also under Polish Academy of Sciences banner) focused on molecular biology, structural biology, and bioinformatics. Direct peer in terms of national scientific institute status, genomics/molecular biology research focus, and Polish Academy of Sciences governance model.
• Institute of Biochemistry and Biophysics PAS: Polish Academy of Sciences research institute in molecular biology, biochemistry, and bioinformatics. Comparable in PAS institutional framework, molecular biology research focus, and bioinformatics capabilities.

Others

• Centogene AG: Commercial genetic diagnostics and multi-omics company headquartered in Germany. Comparable in clinical diagnostic services (especially rare disease and genetic testing), multi-omics capabilities, and serving pharmaceutical/biotech clients, but operates as a commercial entity rather than public institute.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/instytut-genetyki-cz%C5%82owieka-pan

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute of Human Genetics, Polish Academy of Sciences